Mapping of an antigenic site on the nucleocapsid protein of human parainfluenza virus type 3

Viral Immunology

Volumn 22, Issue 3, 2009, Pages 181-188

  Zvirbliene, Aurelija ^a   Sezaite, Indre ^a   Pleckaityte, Milda ^a   Kucinskaite Kodze, Indre ^a   Juozapaitis, Mindaugas ^a   Sasnauskas, Kestutis ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NUCLEOCAPSID PROTEIN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; EPITOPE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE MAPPING; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; SERUM; VIRUS NUCLEOCAPSID; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; BLOOD; EPITOPE MAPPING; FEMALE; GENETICS; IMMUNOLOGY; MEASLES VIRUS; MOLECULAR GENETICS; MOUSE; RNA VIRUS INFECTION; SEQUENCE ALIGNMENT; VIROLOGY;

HUMAN PARAINFLUENZA VIRUS 3; MURINAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; EPITOPE MAPPING; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; MEASLES VIRUS; MICE; MOLECULAR SEQUENCE DATA; NUCLEOCAPSID PROTEINS; PARAINFLUENZA VIRUS 3, HUMAN; RECOMBINANT PROTEINS; RESPIROVIRUS INFECTIONS; SEQUENCE ALIGNMENT;

EID: 67049100233     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0106     Document Type: Article

References (23)

1. Buchholz CJ, Retzler C, Homann HE, and Neubert WT: The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles. Virology 1994;204: 770-776. (Pubitemid 24330882)
2. Cevik B, Kaesberg J, Smallwood S, Feller JA, and Moyer SA: Mapping the phosphoprotein binding site on Sendai virus NP protein assembled into nucleocapsids. Virology 2004; 325:216-224. (Pubitemid 38902788)
3. Coronel EC, Takimoto T, Murti KG, Varich N, and Portner A: Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. J Virol 2001;75:1117-1123. (Pubitemid 32094670)
4. Galinski MS, Mink MA, Lambert DM, Wechsler SL, and Pons MW: Molecular cloning and sequence analysis of the human parainfluenza 3 virus RNA encoding the nucleocapsid protein. Virology 1986;149:139-151. (Pubitemid 16127812)
5. Henrickson JK: Parainfluenza viruses. Clin Microbiol Rev 2003;16:242-264.
6. Juozapaitis M, Zvirbliene A, Kucinskaite I, et al.: Synthesis of recombinant human parainfluenza virus 1 and 3 nucleocapsid proteins in yeast Saccharomyces cerevisiae. Virus Res 2008;133:178-186.
7. Klippmark E, Rydbeck R, Shibuta H, and Norrby E: Antigenic variation of human and bovine parainfluenza virus type 3 strains. J Gen Virol 1990;71:1577-1580. (Pubitemid 20225858)
8. Köhler G, and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256:495-497.
9. Lyn D, Gill DS, Scroggs RA, and Portner A: The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinants. J Gen Virol 1991;72:983-987.
10. Matsuoka Y, and Ray R: Sequence analysis and expression of the human parainfluenza type 1 virus nucleoprotein gene. Virology 1991;181:403-407.
11. Monto AS: The Tecumseh study of respiratory illness. V. Patterns of infection with the parainfluenza viruses. Am J Epidemiol 1973;97:338-348.
12. Ohsawa K, Yamada A, Takeuchi K, Watanabe Y, Miyata H, and Sato H: Genetic characterization of parainfluenza virus 3 derived from guinea pigs. J Vet Med Sci 1998;60:919-922. (Pubitemid 128533524)
13. Orvell C, Rydbeck R, and Löve A: Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies. J Gen Virol 1986;67: 1929-1939. (Pubitemid 16017277)
14. Parks CL, Lerch RA, Walpita P, Wang HP, Sidhu MS, and Udem SA: Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol 2001;75:910-920. (Pubitemid 32037293)
15. Reed G, Jewett PH, Thompson J, Tollefson S, and Wright PF: Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J Infect Dis 1997;175:807-813. (Pubitemid 27142952)
16. Rydbeck R, Orvell C, Löve A, and Norrby E: Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies. J Gen Virol 1986;67:1531-1542. (Pubitemid 16077675)
17. Rota JS, Wang ZD, Rota PA, and Bellini WJ: Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res 1994;31:317-330. (Pubitemid 24073960)
18. Samuel D, Sasnauskas K, Jin L, et al.: Development of a measles specific IgM ELISA for use with serum and oral fluid using recombinant measles nucleocapsid produced in Saccharomyces cervisiae. J Clin Virol 2003;28:121-129. (Pubitemid 37040864)
19. Schmidt AC, McAuliffe JM, Murphy BR, and Collins PL: Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3. J Virol 2001; 75:4594-4603.
20. Vainionpää R, and Hyypiä T: Biology of parainfluenza viruses. Clin Microbiol Rev 1994;7:265-275.
21. Wechsler SL, Lambert DM, Galinski MS, and Pons MW: Intracellular synthesis of human parainfluenza type 3 virusspecified polypeptides. J Virol 1985;54:661-664.
22. Zhao H, and Banerjee AK: Interaction between the nucleocapsid protein and the phosphoprotein of human parainfluenza virus 3. Mapping of the interacting domains using a two-hybrid system. J Biol Chem 1995;270:12485-12490.
23. Zvirbliene A, Kucinskaite I, Sezaite I, Samuel D, and Sasnauskas K: Mapping of B cell epitopes in measles virus nucleocapsid protein. Arch Virol 2007;152:25-39. (Pubitemid 44974613)